Last update: July 21, 2017
Minimal risk for breastfeeding and infant.
A short-term action Sulfonamide which is similar to Sulfathiazole (see specific info) that is locally used on vagina, eyes and skin.
At latest update relevant published data were not found on excretion into breast milk.
Because of the small dose used and poor absorption into plasma of most topical preparations for dermatological and ophthalmological issues, it is unlikely a significant excretion into breast milk.
As with other sulfonamides, caution is recommended when using it on preterm infants and newborns with hyperbilirubinemia. Avoid it on patients affected with deficit of Glucose 6-Phosphate Dehydrogenase (6-GPD). Monitor the appearance of jaundice in the infant.
We do not have alternatives for Sulfacetamide since it is relatively safe.
Suggestions made at e-lactancia are done by APILAM´s pediatricians and pharmacists, and are based on updated scientific publications.
It is not intended to replace the relationship you have with your doctor but to compound it.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
e-lactancia is a resource recommended by Academy of Breastfeeding Medicine from United States of America
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM